Cargando…

Single-nucleotide polymorphism of rs7944135 (macrophage-expressed gene 1) is associated with hepatitis B surface antigen seroclearance in chronic hepatitis B infection: A cohort study

Clearance of the hepatitis B surface antigen (HBsAg) is the ultimate aim of treatment for patients with chronic hepatitis B (CHB) infection. Genetic, factor age, and gender were reported to be involved in the clearance of HBsAg. However, the rate of HBsAg seroclearance in CHB patients is still low g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Irham, Lalu Muhammad, Wong, Henry Sung-Ching, Perwitasari, Dyah Aryani, Chou, Wan-Hsuan, Yang, Hwai-I, Chang, Wei-Chiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940119/ https://www.ncbi.nlm.nih.gov/pubmed/31860948 http://dx.doi.org/10.1097/MD.0000000000017936

Ejemplares similares

Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients
por: Ungtrakul, Teerapat, et al.
Publicado: (2017)

Evaluation for the Genetic Association between Store-Operated Calcium Influx Pathway (STIM1 and ORAI1) and Human Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection
por: Muhammad Irham, Lalu, et al.
Publicado: (2020)

Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach
por: Irham, Lalu Muhammad, et al.
Publicado: (2022)

The use of genomic variants to drive drug repurposing for chronic hepatitis B
por: Irham, Lalu Muhammad, et al.
Publicado: (2022)

Cumulative incidence of hepatocellular carcinoma and hepatitis B surface antigen Seroclearance after Nucleos(t) ide analogue-induced hepatitis B e antigen Seroclearance
por: Lee, Hyun Woong, et al.
Publicado: (2020)

Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection
por: Yang, Wan-Ting, et al.
Publicado: (2016)

Antibody to Hepatitis B Core Antigen Levels in the Natural History of Chronic Hepatitis B: A Prospective Observational Study
por: Jia, Wei, et al.
Publicado: (2014)

Artificial Neural Network Accurately Predicts Hepatitis B Surface Antigen Seroclearance
por: Zheng, Ming-Hua, et al.
Publicado: (2014)

Identification of Druggable Genes for Asthma by Integrated Genomic Network Analysis
por: Adikusuma, Wirawan, et al.
Publicado: (2022)

Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B
por: Kim, Tae Hyung, et al.
Publicado: (2018)

Drug Repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information
por: Adikusuma, Wirawan, et al.
Publicado: (2021)

Clinical features of chronic hepatitis B patients with low hepatitis B surface antigen levels and determinants of hepatitis B surface antigen seroclearance
por: Taniguchi, Hideaki, et al.
Publicado: (2020)

Antenatal administration of hepatitis B immunoglobulin and hepatitis B vaccine to prevent mother to child transmission in hepatitis B virus surface antigen positive pregnant women: A systematic review and meta-analysis
por: Chen, Zhe, et al.
Publicado: (2020)

Using Machine Learning Algorithms to Predict Hepatitis B Surface Antigen Seroclearance
por: Tian, Xiaolu, et al.
Publicado: (2019)

Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection
por: Wu, Shuling, et al.
Publicado: (2022)

Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
por: Jang, Tyng-Yuan, et al.
Publicado: (2023)

Evaluation of HBsAg Seroclearance in Patients with Hepatitis B
por: Taşkın, Mehmet Can, et al.
Publicado: (2022)

Long-term Hepatitis B Surface Antigen Profile and Seroclearance after Severe Acute Flares of Chronic Hepatitis B
por: Hui, Ka-Yin, et al.
Publicado: (2023)

Hepatitis B viremia in completely immunized individuals negative for anti-hepatitis B core antibody
por: Lai, Ming-Wei, et al.
Publicado: (2016)

Improved Efficacy of a Pegylated Interferon-α-2a Stepwise Optimization Treatment Strategy in the Treatment of Hepatitis B e Antigen-positive Chronic Hepatitis B Patients
por: Zhou, Pu, et al.
Publicado: (2015)

Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis
por: Afief, Arief Rahman, et al.
Publicado: (2022)

Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients
por: Cheng, Huei-Ru, et al.
Publicado: (2013)

Spontaneous Hepatitis B Seroclearance upon Development of Hepatocellular Carcinoma
por: Naimimohasses, Sara, et al.
Publicado: (2017)

Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients
por: Li, Min-Ran, et al.
Publicado: (2016)

Cellular immune responses in patients with hepatitis B surface antigen seroclearance induced by antiviral therapy
por: Liang, Minfeng, et al.
Publicado: (2011)

Combination therapy based on pegylated interferon alfa improves the therapeutic response of patients with chronic hepatitis B who exhibit high levels of hepatitis B e-antigen at 24 weeks: A retrospective observational study
por: Zhang, Yafei, et al.
Publicado: (2019)

Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance
por: Jang, Jeong Won, et al.
Publicado: (2021)

Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis
por: Hoang, Joseph K., et al.
Publicado: (2016)

Negative impact of hepatitis B surface seroclearance on prognosis of hepatitis B-related primary liver cancer
por: Lou, Cheng, et al.
Publicado: (2018)

Virological and serological features of acute hepatitis B in adults
por: Du, Xiaofei, et al.
Publicado: (2017)

Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: A meta‐analysis
por: Song, Aixin, et al.
Publicado: (2021)

Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance
por: Park, Yewan, et al.
Publicado: (2021)

Long-Term Effect of Interferon Plus Ribavirin on Hepatitis B Surface Antigen Seroclearance in Patients Dually Infected with Hepatitis B and C Viruses
por: Yeh, Ming-Lun, et al.
Publicado: (2011)

Metabolic-Associated Fatty Liver Disease, Hepatitis B Surface Antigen Seroclearance, and Long-Term Risk of Hepatocellular Carcinoma in Chronic Hepatitis B
por: Yu, Ming-Whei, et al.
Publicado: (2022)

Comparison of collagen proportionate areas in liver fibrosis quantification between chronic hepatitis B and C
por: Chen, Sheng-Hung, et al.
Publicado: (2016)

Effect of tenofovir on renal function in patients with chronic hepatitis B
por: Jung, Woo Jin, et al.
Publicado: (2018)

The Role of Steatosis in HBsAg Seroclearance for Patients with Chronic Hepatitis B Infection: Fact or Fiction?
por: Fung, James, et al.
Publicado: (2012)

Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study
por: Yeh, Ming-Lun, et al.
Publicado: (2015)

Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B
por: Lee, I-Cheng, et al.
Publicado: (2015)

Expression and significance of urinary microRNA in patients with chronic hepatitis B
por: Shang, Jia-Wei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_snokcofck41cdvi6uulgb5qate